Shareholder Interest
13 Octubre 2005 - 12:20PM
UK Regulatory
RNS Number:6574S
Biotrace International PLC
13 October 2005
For immediate release 13 October 2005
Biotrace International Plc (the "Company")
Shareholder Interest
Biotrace International a leading manufacturer of industrial microbiology and
life science products and services announces that yesterday it was informed that
Armor Capital Management, LLC and certain subsidiary companies have increased
their holding in Biotrace with the purchase of 350,000 ordinary shares. Armor
Capital Management, LLC now have an aggregated interest in 2,096,500 shares
representing 5.34 per cent. of the issued share capital of the Company.
The shares are held by the following entities:
Armor Capital Partners, LP - 1,882,500 shares held at UBS Securities, LLC in New York
Abeille Value Holdings, LLC - 24,000 shares held at UBS Securities, LLC in New York
First New York Securities, LLC - 190,000 shares held at Bear Stearns Securities in New York
For further information please contact
Peter Morgan, Finance Director Tel: 01656 641400
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFFUFWDSISEFS
Bank Irel13.375 (LSE:BOI)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Bank Irel13.375 (LSE:BOI)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Bank Irel13.375 (London Stock Exchange): 0 recent articles
Más de Biotrace Int. Artículos de Noticias